Leonard T Buller1, Samuel Rosas2, Karim G Sabeh1, Martin W Roche3, Alexander S McLawhorn4, Wael K Barsoum5. 1. Department of Orthopaedic Surgery, Jackson Memorial Hospital, University of Miami, Miami, Florida. 2. Department of Orthopaedic Surgery, Wake Forest University, Winston-Salem, North Carolina. 3. Department of Orthopaedic Surgery, Holy Cross Hospital, Ford Lauderdale, Florida. 4. Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, New York. 5. Department of Orthopaedic Surgery, Cleveland Clinic Florida, Weston, Florida.
Abstract
BACKGROUND: Thyroid disease is common and often remains undetected in the US population. Thyroid hormone has an array of metabolic, immunologic, and musculoskeletal functions crucial to well-being. The influence of thyroid disease on perioperative outcomes following primary total knee arthroplasty (TKA) is poorly understood. We hypothesized that hypothyroidism was associated with a higher risk of postoperative complications and 90-day costs following primary TKA. METHODS: The Medicare standard analytical files were queried using International Classification of Disease codes between 2005 and 2014 to identify patients undergoing primary TKA. Patients with a diagnosis of hypothyroidism were matched by age and gender on a 1:1 ratio. Ninety-day postoperative complication rates, day of surgery, and 90-day global period charges and reimbursements were compared between matched cohorts. RESULTS: A total of 2,369,594 primary TKAs were identified between 2005 and 2014. After age and gender matching, each cohort consisted of 98,555 patients. Hypothyroidism was associated with greater odds of postoperative complications compared to matched controls (odds ratio 1.367, 95% confidence interval 1.322-1.413). The 90-day incidence of multiple postoperative medical and surgical complications, including periprosthetic joint infection, was higher among patients with hypothyroidism. Day of surgery and 90-day episode of care costs were significantly higher in the hypothyroidism cohort. CONCLUSION: This study demonstrated an increased risk of multiple postoperative complications and higher costs among patients with hypothyroidism following primary TKA. Surgeons should counsel patients on these findings and seek preoperative optimization strategies to reduce these risks and lower costs in this patient population.
BACKGROUND:Thyroid disease is common and often remains undetected in the US population. Thyroid hormone has an array of metabolic, immunologic, and musculoskeletal functions crucial to well-being. The influence of thyroid disease on perioperative outcomes following primary total knee arthroplasty (TKA) is poorly understood. We hypothesized that hypothyroidism was associated with a higher risk of postoperative complications and 90-day costs following primary TKA. METHODS: The Medicare standard analytical files were queried using International Classification of Disease codes between 2005 and 2014 to identify patients undergoing primary TKA. Patients with a diagnosis of hypothyroidism were matched by age and gender on a 1:1 ratio. Ninety-day postoperative complication rates, day of surgery, and 90-day global period charges and reimbursements were compared between matched cohorts. RESULTS: A total of 2,369,594 primary TKAs were identified between 2005 and 2014. After age and gender matching, each cohort consisted of 98,555 patients. Hypothyroidism was associated with greater odds of postoperative complications compared to matched controls (odds ratio 1.367, 95% confidence interval 1.322-1.413). The 90-day incidence of multiple postoperative medical and surgical complications, including periprosthetic joint infection, was higher among patients with hypothyroidism. Day of surgery and 90-day episode of care costs were significantly higher in the hypothyroidism cohort. CONCLUSION: This study demonstrated an increased risk of multiple postoperative complications and higher costs among patients with hypothyroidism following primary TKA. Surgeons should counsel patients on these findings and seek preoperative optimization strategies to reduce these risks and lower costs in this patient population.
Authors: Sherita H Golden; Karen A Robinson; Ian Saldanha; Blair Anton; Paul W Ladenson Journal: J Clin Endocrinol Metab Date: 2009-06 Impact factor: 5.958
Authors: Milford H Marchant; Nicholas A Viens; Chad Cook; Thomas Parker Vail; Michael P Bolognesi Journal: J Bone Joint Surg Am Date: 2009-07 Impact factor: 5.284
Authors: Gillian A Hawker; Elizabeth M Badley; Ruth Croxford; Peter C Coyte; Richard H Glazier; Jun Guan; Bart J Harvey; J I Williams; James G Wright Journal: Med Care Date: 2009-07 Impact factor: 2.983
Authors: Gerry Oster; Daniel A Ollendorf; Montserrat Vera-Llonch; May Hagiwara; Ariel Berger; John Edelsberg Journal: Ann Pharmacother Date: 2004-01-12 Impact factor: 3.154
Authors: Chester J Donnally; Ajit M Vakharia; Jonathan I Sheu; Rushabh M Vakharia; Dhanur Damodar; Kartik Shenoy; Joseph P Gjolaj Journal: Global Spine J Date: 2019-02-26
Authors: Samuel Rosas; Michael Schallmo; Anirudh Krishna Gowd; Matthew Reynolds Akelman; T David Luo; Cynthia Lynn Emory; Johannes Frank Plate Journal: World J Orthop Date: 2021-06-18